As in previous investigations, our study showed a high incidence of TB in patients with rheumatic diseases exposed to TNF inhibitors therapy: 735.29 per 100,000 exposed, approximately 18 times higher than that of the general population of the state of Rio Grande do Sul (39.5 per 100,000).[24]. This evidence concerns the gene TNF and tuberculosis.